Part of Novo Nordisk’s contribution to promoting access to care is our continued long-term financial commitment to the World Diabetes Foundation (WDF).
The World Diabetes Foundation was established by Novo Nordisk in 2002 as an independent trust dedicated to the prevention and treatment of diabetes in developing countries. The Foundation supports sustainable partnerships and acts as a catalyst to help others do more.
Novo Nordisk has donated a total of DKK 1.78 billion (USD 329 million) to the Foundation, to be allocated in the period 2001–2024.
Visit the World Diabetes Foundation website.
Why do 80% of people with diabetes live in developing countries? And what can be done about it? See this film and learn how partnerships are improving health systems and lives in Tanzania, and worldwide.